Tanner Pharma Group: Tanner Pharma Increases Europe-Based Inventory of Leukine to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine
Leukine is FDA Approved to Treat Acute Radiation Syndrome (ARS) and Recommended in EMEA/CPMP Guidance to Treat Systemic Sulfur Mustard (HD) Gas Exposure Tanner Pharma Group, an international distributor